These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 21665908

  • 1. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer.
    Kawaguchi Y, Nishiyama K, Miyagi K, Suzuki O, Ito Y, Nakamura S.
    Jpn J Clin Oncol; 2011 Aug; 41(8):1007-12. PubMed ID: 21665908
    [Abstract] [Full Text] [Related]

  • 2. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Li DJ, Li HW, He B, Wang GM, Cai HF, Duan SM, Liu JJ, Zhang YJ, Cui Z, Jiang H.
    J BUON; 2016 Aug; 21(5):1268-1273. PubMed ID: 27837632
    [Abstract] [Full Text] [Related]

  • 3. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy.
    Liu H, Lu L, Zhu Q, Hao Y, Mo Y, Liu M, Hu Y, Cui N, Rong T.
    Radiother Oncol; 2011 May; 99(2):181-6. PubMed ID: 21620504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy.
    Park JW, Kim JH, Choi EK, Lee SW, Yoon SM, Song SY, Lee YS, Kim SB, Park SI, Ahn SD.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):691-7. PubMed ID: 20888705
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Impact of different extents of lymph node dissection on the survival in stage III esophageal cancer patients].
    Zhang GQ, Han F, Sun W, Pang ZL, SiKanDaer AB, Wang HJ.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 01; 30(11):858-62. PubMed ID: 19173833
    [Abstract] [Full Text] [Related]

  • 10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T, Muto M, Hattori S, Minashi K, Onozawa M, Nihei K, Ishikura S, Ohtsu A, Yoshida S.
    Endoscopy; 2008 Sep 01; 40(9):717-21. PubMed ID: 18773340
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: a single institute experience.
    Sasaki T, Nakamura K, Shioyama Y, Toh Y, Okamura K, Ohura H, Hirata H, Honda H.
    Am J Clin Oncol; 2007 Oct 01; 30(5):514-9. PubMed ID: 17921713
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M, Iwahashi M, Nakamura M, Yamaue H.
    J Surg Oncol; 2003 Sep 01; 84(1):10-6. PubMed ID: 12949985
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G, Wang Z, Liu XY, Zhang MY, Liu FY.
    Eur J Cardiothorac Surg; 2009 Jan 01; 35(1):1-7. PubMed ID: 18926712
    [Abstract] [Full Text] [Related]

  • 19. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.
    Button MR, Morgan CA, Croydon ES, Roberts SA, Crosby TD.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):818-23. PubMed ID: 18718726
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.